Ivermectin Research Overview
Iverheal 3 mg is an antiparasitic compound manufactured by Healing Pharma for laboratory research applications. Ivermectin belongs to the avermectin class of molecules, originally derived from Streptomyces avermitilis fermentation products. This formulation contains 3mg of ivermectin per tablet, enabling precise dosing for experimental protocols. Researchers at Stroid UK Shop frequently investigate ivermectin’s mechanism of action through glutamate-gated chloride channel binding studies and its effects on various parasitic models.
Laboratory Applications
Scientists examine ivermectin’s broad-spectrum activity against ectoparasites and endoparasites in controlled laboratory settings. The compound demonstrates efficacy in research models studying onchocerciasis, lymphatic filariasis, and strongyloidiasis pathways. Recent studies have expanded to investigate potential antiviral properties, particularly examining RNA-dependent RNA polymerase inhibition mechanisms. Researchers within our antiviral drugs collection often compare ivermectin’s activity profiles with other compounds. Laboratory protocols typically evaluate cellular uptake kinetics, protein binding interactions, and metabolic pathway modulation in various cell lines and tissue preparations.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Ivermectin |
| Strength | 3mg per tablet |
| Manufacturer | Healing Pharma |
| CAS Number | 70288-86-7 |
| Molecular Formula | C48H74O14 |
| Molecular Weight | 875.10 g/mol |
| Storage | Room temperature, dry conditions |
Researchers often integrate ivermectin studies with investigations from our SARMs category and peptides section to examine multi-pathway therapeutic approaches. The compound’s lipophilic properties facilitate membrane penetration studies, while its extended half-life enables longitudinal research protocols examining sustained biological effects.
Research Compliance
This product is strictly for in-vitro research and laboratory analysis only. Iverheal 3mg is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must adhere to institutional guidelines and regulatory requirements when handling this compound. All studies should be conducted in appropriate laboratory facilities with proper safety protocols and waste disposal procedures.
